Green Cross holds launching symposium over Abraxane
Green Cross Corporation held its symposium for Abraxane, paclitaxel protein-bound particles for injectable suspension, at Grand Intercontinental hotel on July 10.
Abraxane is indicated for the treatment of breast cancer after failure of co...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
